The planned merger of Glaxo and Wellcome raises questions broader than the interests of shareholders.
Article PDF
Rights and permissions
About this article
Cite this article
Mergers mean risks. Nature 374, 2 (1995). https://doi.org/10.1038/374002a0
Issue Date:
DOI: https://doi.org/10.1038/374002a0